General Information of Target

Target ID LDTP07866
Target Name Cytochrome P450 4V2 (CYP4V2)
Gene Name CYP4V2
Gene ID 285440
Synonyms
Cytochrome P450 4V2; Docosahexaenoic acid omega-hydroxylase CYP4V2; EC 1.14.14.79; Long-chain fatty acid omega-monooxygenase; EC 1.14.14.80
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MAGLWLGLVWQKLLLWGAASALSLAGASLVLSLLQRVASYARKWQQMRPIPTVARAYPLV
GHALLMKPDGREFFQQIIEYTEEYRHMPLLKLWVGPVPMVALYNAENVEVILTSSKQIDK
SSMYKFLEPWLGLGLLTSTGNKWRSRRKMLTPTFHFTILEDFLDIMNEQANILVKKLEKH
INQEAFNCFFYITLCALDIICETAMGKNIGAQSNDDSEYVRAVYRMSEMIFRRIKMPWLW
LDLWYLMFKEGWEHKKSLQILHTFTNSVIAERANEMNANEDCRGDGRGSAPSKNKRRAFL
DLLLSVTDDEGNRLSHEDIREEVDTFMFEGHDTTAAAINWSLYLLGSNPEVQKKVDHELD
DVFGKSDRPATVEDLKKLRYLECVIKETLRLFPSVPLFARSVSEDCEVAGYRVLKGTEAV
IIPYALHRDPRYFPNPEEFQPERFFPENAQGRHPYAYVPFSAGPRNCIGQKFAVMEEKTI
LSCILRHFWIESNQKREELGLEGQLILRPSNGIWIKLKRRNADER
Target Bioclass
Enzyme
Family
Cytochrome P450 family
Subcellular location
Endoplasmic reticulum membrane
Function
A cytochrome P450 monooxygenase involved in fatty acid metabolism in the eye. Catalyzes the omega-hydroxylation of polyunsaturated fatty acids (PUFAs) docosahexaenoate (DHA) and its precursor eicosapentaenoate (EPA), and may contribute to the homeostasis of these retinal PUFAs. Omega hydroxylates saturated fatty acids such as laurate, myristate and palmitate, the catalytic efficiency decreasing in the following order: myristate > laurate > palmitate (C14>C12>C16). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase).
Uniprot ID
Q6ZWL3
Ensemble ID
ENST00000378802.5
HGNC ID
HGNC:23198

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
AN3CA SNV: p.P58T DBIA    Probe Info 
CCK81 SNV: p.Y84C DBIA    Probe Info 
IGR37 SNV: p.S492F .
IGR39 SNV: p.S492F .
JURKAT SNV: p.V220I .
KYSE30 SNV: p.K471R .
MFE280 SNV: p.M123I .
NCIH1155 SNV: p.A273V .
NCIH23 Deletion: p.F445SfsTer24
SNV: p.R368L
.
OVK18 Insertion: p.Y191LfsTer12 .
RL SNV: p.S347C .
SKN SNV: p.F162L DBIA    Probe Info 

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 1 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C282(0.96); C406(1.48)  LDD3320  [1]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0022  KB02 A101D C282(1.91)  LDD2250  [1]
 LDCM0023  KB03 A101D C282(2.07)  LDD2667  [1]
 LDCM0024  KB05 RVH421 C282(0.96); C406(1.48)  LDD3320  [1]

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840